Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis

J. Altenburg (Amsterdam , Netherlands), J. Chalmers (Dundee, United Kingdom), M. Lonergan (Dundee, United Kingdom), L. Jayaram (Melbourne, Australia), L. Burr (Brisbane, Australia), M. Crichton (Dundee, United Kingdom), N. Karalus (Hamilton, New Zealand), M. Martin (Brisbane, Australia), S. Taylor (Adelaide, Australia), C. Wong (Auckland, New Zealand), W. Boersma (Alkmaar, Netherlands)

Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Session: Advances in bronchiectasis and non-TB mycobacterial infections
Session type: Oral Presentation
Number: 4945
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Altenburg (Amsterdam , Netherlands), J. Chalmers (Dundee, United Kingdom), M. Lonergan (Dundee, United Kingdom), L. Jayaram (Melbourne, Australia), L. Burr (Brisbane, Australia), M. Crichton (Dundee, United Kingdom), N. Karalus (Hamilton, New Zealand), M. Martin (Brisbane, Australia), S. Taylor (Adelaide, Australia), C. Wong (Auckland, New Zealand), W. Boersma (Alkmaar, Netherlands). Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis. 4945

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: